Origin Materials, Inc. (NASDAQ:ORGN) is a technology company that focuses on creating sustainable materials. On November 14, 2024, ORGN reported its third-quarter earnings, revealing an earnings per share (EPS) of -$0.26, which was below the expected -$0.11. The company's revenue was approximately $8.2 million, missing the estimated $9.1 million.
During the Q3 2024 earnings call, key figures like Co-CEOs Rich Riley and John Bissell, and CFO Matt Plavan, discussed the company's performance. Despite the earnings miss, ORGN achieved a milestone with its CapFormer System, which showed over 98% manufacturing efficiency. This system is set to produce the first commercially viable PET caps, with commercial production expected by year-end.
The price-to-sales ratio of 4.52 suggests investors are paying $4.52 for every dollar of sales. The enterprise value to sales ratio of 3.20 provides a perspective on the company's valuation compared to its sales.
ORGN's financial health is mixed. The enterprise value to operating cash flow ratio is -1.90, indicating negative operating cash flow. However, the company maintains a low debt-to-equity ratio of 0.027, showing minimal debt compared to equity. Additionally, a strong current ratio of 16.27 suggests ORGN can easily cover its short-term liabilities with its assets.
Symbol | Price | %chg |
---|---|---|
BRPT.JK | 2190 | 2.74 |
051910.KS | 277500 | -1.44 |
051915.KS | 136500 | -2.56 |
4063.T | 4557 | -0.88 |
Origin Materials, Inc. (NASDAQ:ORGN) is a technology company based in West Sacramento, California, focused on developing sustainable materials. The company aims to facilitate the global shift towards environmentally friendly products. Recently, ORGN introduced its first Origin PET bottlecaps, marking a significant step in its mission. Despite these advancements, ORGN faces financial challenges, as reflected in its recent earnings report.
On August 14, 2025, ORGN reported its earnings, revealing an earnings per share (EPS) of -$0.097, slightly below the estimated EPS of -$0.09. The company's actual revenue was $5.8 million, significantly missing the estimated $29.1 million. This shortfall highlights the financial difficulties ORGN is currently experiencing, as evidenced by its negative price-to-earnings (P/E) ratio of approximately -1.28.
During the Q2 2025 earnings conference call, key company figures, including CEO John Bissell and CFO Matthew T. Plavan, discussed ORGN's financial performance and strategic initiatives. Despite the challenges, ORGN maintains a low debt-to-equity ratio of about 0.024, indicating minimal reliance on debt. This financial structure could provide stability as the company navigates its current difficulties.
ORGN's price-to-sales ratio stands at about 4.21, suggesting that investors are willing to pay $4.21 for every dollar of sales. However, the enterprise value to operating cash flow ratio is negative at around -2.10, reflecting challenges in generating positive cash flow from operations. This negative earnings yield of approximately -0.78% further underscores the company's financial struggles.
Despite these challenges, ORGN's strong current ratio of approximately 9.51 indicates a robust ability to cover short-term liabilities with short-term assets. This financial strength could support the company as it continues to focus on its mission of advancing sustainable materials, even as it works to improve its financial performance.
Origin Materials, Inc. (NASDAQ:ORGN) is a technology company that focuses on creating sustainable materials. On November 14, 2024, ORGN reported its third-quarter earnings, revealing an earnings per share (EPS) of -$0.26, which was below the expected -$0.11. The company's revenue was approximately $8.2 million, missing the estimated $9.1 million.
During the Q3 2024 earnings call, key figures like Co-CEOs Rich Riley and John Bissell, and CFO Matt Plavan, discussed the company's performance. Despite the earnings miss, ORGN achieved a milestone with its CapFormer System, which showed over 98% manufacturing efficiency. This system is set to produce the first commercially viable PET caps, with commercial production expected by year-end.
The price-to-sales ratio of 4.52 suggests investors are paying $4.52 for every dollar of sales. The enterprise value to sales ratio of 3.20 provides a perspective on the company's valuation compared to its sales.
ORGN's financial health is mixed. The enterprise value to operating cash flow ratio is -1.90, indicating negative operating cash flow. However, the company maintains a low debt-to-equity ratio of 0.027, showing minimal debt compared to equity. Additionally, a strong current ratio of 16.27 suggests ORGN can easily cover its short-term liabilities with its assets.